The cost-efficiency, simplicity and precision of the DANBY m60 Human-Powered Syringe Driver makes it suitable for a broad range of medical application where one or more of these benefits scores over existing device categories.
Pain Management and Chronic Pain
The low capital cost of this device means hospitals will more readily discharge patients with the device for home use. It is simple to use and requires less training than a complex volumetric pump.
Oncology
The patient can be discharged from the hospital with complex drug delivery regimes and then attended at the end of delivery once they are home. Unlike an elastomeric device, its end of delivery time is easy to predict accurately so healthcare visits take place without wasted time. If the StepwiseTM Smart Syringe is used, a needle-safe sequential delivery is provided with minimal supervision.
Chronic Patient-Managed Conditions
Users at home who administer regular infusions, benefit from the improved mobility of this light and compact ambulatory device.
The lack of batteries means users are free from the burden of stocking, charging and swapping cells, and free from the worry about end of battery life in use.
Biologics and Slow Injection
This delivery of this new class of formulations is often too slow and hard to inject and too small to infuse with conventional pumps.
A small yet powerful syringe driver can be more suited to the task. The added advantage of the DANBY m60 is that it can adapt the delivery flowrate within managed limits to make the injection more comfortable for the user.
Emergency & Stabilisation
The self-powered nature of the DANBY m60 gives it exceptional shelf-life and immediate deployment to treat emergency cases such as strokes and heart attacks and to deliver PCA. Its compactness and mobility is particularly suited to keeping patients stable during handling, transfer and repatriation from the field to hospital.
Developing World Applications
Because the DANBY m60 needs no additional power it is suitable for remote areas where the utilities and infrastructure aren’t adequate to support many of the complex delivery devices. Danby provides control and precise infusion, extending the advanced treatments that need this to a broader population.
Pain Management and Chronic Pain
The low capital cost of this device means hospitals will more readily discharge patients with the device for home use. It is simple to use and requires less training than a complex volumetric pump.
Oncology
The patient can be discharged from the hospital with complex drug delivery regimes and then attended at the end of delivery once they are home. Unlike an elastomeric device, its end of delivery time is easy to predict accurately so healthcare visits take place without wasted time. If the StepwiseTM Smart Syringe is used, a needle-safe sequential delivery is provided with minimal supervision.
Chronic Patient-Managed Conditions
Users at home who administer regular infusions, benefit from the improved mobility of this light and compact ambulatory device.
The lack of batteries means users are free from the burden of stocking, charging and swapping cells, and free from the worry about end of battery life in use.
Biologics and Slow Injection
This delivery of this new class of formulations is often too slow and hard to inject and too small to infuse with conventional pumps.
A small yet powerful syringe driver can be more suited to the task. The added advantage of the DANBY m60 is that it can adapt the delivery flowrate within managed limits to make the injection more comfortable for the user.
Emergency & Stabilisation
The self-powered nature of the DANBY m60 gives it exceptional shelf-life and immediate deployment to treat emergency cases such as strokes and heart attacks and to deliver PCA. Its compactness and mobility is particularly suited to keeping patients stable during handling, transfer and repatriation from the field to hospital.
Developing World Applications
Because the DANBY m60 needs no additional power it is suitable for remote areas where the utilities and infrastructure aren’t adequate to support many of the complex delivery devices. Danby provides control and precise infusion, extending the advanced treatments that need this to a broader population.